Company Filing History:
3 out of 11 
2 out of 4 
1 out of 5 Years Active: 2000-2005
Title: Gregory F Oxenkrug: Innovator in Depression Treatment
Introduction
Gregory F Oxenkrug is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of depression. With a total of six patents to his name, Oxenkrug's work focuses on innovative compounds and methods aimed at improving mental health.
Latest Patents
Among his latest patents is the development of 5-methoxy-carbonylamino-N-acetyltryptamine compounds and derivatives thereof. This invention includes compositions that utilize these compounds for the treatment of depression. Additionally, he has patented a method for treating depression, which involves administering a therapeutically effective amount of M-3 agonists, 5-MCA-NAT, or an analog to individuals diagnosed with depression. This method may be used alone or in combination with other agents, such as calcium antagonists.
Career Highlights
Oxenkrug has worked with reputable institutions, including St. Elizabeth's Medical Center of Boston, Inc. and St. Elizabeth's Medical Center. His experience in these organizations has contributed to his expertise in the medical field and his innovative approaches to treatment.
Collaborations
Some of his notable coworkers include Pura J Requintina and Sergei O Bachurin. Their collaboration has likely played a role in advancing research and development in the area of mental health.
Conclusion
Gregory F Oxenkrug's contributions to the treatment of depression through his innovative patents highlight his dedication to improving mental health. His work continues to influence the field and offers hope for effective treatments.